CRISPR Therapeutics AG (CRSP) |
|
48.5 -0.78 (-1.58%)
|
07-16 16:00 |
|
Open: |
49.38 |
Pre. Close: |
49.28 |
|
High:
|
49.58 |
Low:
|
47.935 |
|
Volume:
|
425,764 |
Market Cap:
|
2659M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
50.115 - 50.362 |
50.362 - 50.612 |
|
Low:
|
47.974 - 48.228 |
48.228 - 48.485 |
|
Close:
|
48.871 - 49.274 |
49.274 - 49.683 |
|
Technical analysis |
as of: 2019-07-16 3:19:53 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 58.69 One year: 68.55 |
| Support: |
Support1: 44.84 Support2: 41.49 |
| Resistance: |
Resistance1: 50.25 Resistance2: 58.69 |
| Pivot: |
47.43  |
| Moving Average: |
MA(5): 49.13 MA(20): 46.99
MA(100): 40.19 MA(250): 39.84 |
| MACD: |
MACD(12,26): 1.89 Signal(9): 1.93 |
| Stochastic oscillator: |
%K(14,3): 81.20 %D(3): 85.08 |
| RSI: |
RSI(14): 59.61 |
| 52-week: |
High: 61.97 Low: 22.22 Change(%): -22.2 |
| Average Vol(K): |
3-Month: 51722 10-Days: 37163 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.CRSP has closed below upper band by 37.9%. Bollinger Bands are 8.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 10 Jul 2019 14:08:59 Z
Here's Why CRISPR Gene Editing Stocks Rose as Much as 32.4% in June
Sat, 29 Jun 2019 22:06:46 Z
3 Growth Stocks to Buy and Hold for the Next 50 Years
Tue, 11 Jun 2019 11:08:16 Z
Is the Newest Gene Editing Stock a Buy?
Mon, 10 Jun 2019 15:15:25 Z
CRISPR Therapeutics Up on Collaboration Expansion by Vertex
Sun, 09 Jun 2019 18:15:42 Z
Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy?
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
